Navigation Links
Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease

bacterial infections with Astellas Pharma Inc. and the Beyond Advair collaboration with GlaxoSmithKline. By leveraging its proprietary insight of multivalency to drug discovery focused on validated targets, Theravance is pursuing a next generation drug discovery strategy designed to discover superior medicines in large markets. For more information, please visit the Company's web site at www.theravance.com.

(1) Ducel G et al. Prevention of Hospital-Acquired Infections. World Health Organization 2002.

(2) Global Patient Safety Challenge 2005 - 2006 http://www.who.int/patientsafety/events/05/GPSC_Launch_ENGLISH_FINAL.pdf

(3) Pittet D, Taraara D, Wenzel RP. Nosocomial bloodstream infections in critically ill patients. Excess length of stay, extra costs, and attributable mortality.JAMA,1994,271:1598-1601.

(4) Kirkland KB et al. The impact of surgical-site infections in the 1990's: attributable mortality, excess length of hospitalization and extra costs. Infect Contr Hosp Epidemiol,1999,20:725-730.

(5) Wakefield DS et al. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem cost in serious Staphylococcus aureus infections. Amer J Infect Control,1988,16:185-192.

(6) Corey GR et al. ATLAS 1: The first Phase 3 study evaluating the new lipoglycopeptide, telavancin, for the treatment of patients with complicated skin and skin structure infections (cSSSIs). ECCMID, Munich. Abstract number (tbd).

(7) Corey GR et al. ATLAS 2: a double-blind, randomised, active controlled, multinational Phase 3 study comparing telavancin with vancomycin for the treatment of patients with complicated skin and skin structure infections (cSSSIs). ECCMID, Munich. Abstract number (tbd).

(8) Cornely AJ et al. An analysis of the efficacy of micafu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
5. Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study
6. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
9. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
10. Alzheimers Drug Shows Promise in Fighting Cancer
11. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
Post Your Comments:
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... Synthesis Market by Product & Services (Equipment, Reagent, ... Biotechnology), Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, ... by MarketsandMarkets, the global Oligonucleotide Synthesis Market is ... $1,070.7 Million in 2014, growing at a CAGR ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... 2011 Cynosure, Inc. (Nasdaq: CYNO ), ... invasive and non-invasive aesthetic applications, today announced that two ... cellulite reduction have received key international regulatory clearances. ... License authorizing the sale in Canada of the company,s ...
... SANTA CLARA, Calif., March 15, 2011 NewCardio, Inc. (OTC Bulletin ... today that the Company expects to file its Form 10-K for ... management will conduct a conference call to provide a corporate update ... Corporate Update Conference Call When : 1:30 p.m. ...
Cached Medicine Technology:Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 2Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 3NewCardio to Conduct Corporate Update Conference Call on March 29, 2011 2
(Date:8/30/2014)... 2014: The first recommendations on the use of ... published today in new ESC Guidelines. The guidelines ... V. Konstantinides (Germany/Greece) and Professor Adam Torbicki (Poland). ... and management of acute pulmonary embolism" are published ... on the ESC Website. , Venous thromboembolism (VTE) ...
(Date:8/29/2014)... The Enchant Him review that was recently published by ... system that promises to teach ladies how to gain control ... who actually is a popular relationship expert and coach. ... advices out there, Carrie worked at this program with Nick ... is a simple to use step by step method. This ...
(Date:8/29/2014)... 29, 2014 The Fibroids Miracle review indicates ... naturally. The program promises fast and powerful results. It actually ... caused by fibroids in only 12 hours. The method promises ... The new system is based on a 3 step method ... its review that the program was in fact created by ...
(Date:8/29/2014)... Colorado (PRWEB) August 29, 2014 According to ... popular hardware detection tool at the moment, as it is ... the best hardware detection tool in the industry. , ... any customer hardware driver. The new program is highly effective ... devices to work perfectly. , Daily Gossip writes in ...
(Date:8/29/2014)... Cosmetic Town has devised a system ... its doctors. Cosmetic Town utilizes a validated referral ... in their field are chosen to present their procedure. ... direct link to potentially hundreds of recommended doctors in ... to communicate through the site’s community features and multimedia ...
Breaking Medicine News(10 mins):Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Enchant Him Review Reveals Unique Relationship Tips for Women 2Health News:Fibroids Miracle Review Exposes Amanda Leto’s 3-Step Holistic System 2Health News:Driver Robot Review Exposes Popular Hardware Detection Tool 2Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2
... resistant to targeted therapy drugs has revealed two previously ... March 23 Science Translational Medicine , investigators from ... how the cellular nature of some tumors actually changes ... can disappear after treatment is discontinued. The findings ...
... , WEDNESDAY, March 23 (HealthDay News) -- ... become resistant to targeted drug therapy. Researchers at ... from 37 patients with non-small cell lung cancer, the ... new genetic changes associated with resistance. They also ...
... study of its kind, urologists and biostatisticians at Henry Ford ... glands is safe over the long term, with a major ... published online this month by the journal European Urology, ... 87 percent of patients whose cancerous prostates were removed by ...
... , TUESDAY, March 22 (HealthDay News) -- Trauma injury patients ... weeknight are no more likely to die than those who ... The findings contrast with previous research that said patients with ... outcomes if they arrive at the hospital at night or ...
... every year there are reports of a young, apparently healthy athlete ... of Wes Leonard, a junior at Fennville High School, who died ... have parents and coaches wondering if enough is being done to ... to develop a better screening program to help prevent sudden cardiac ...
... at Virginia Commonwealth University Massey Cancer Center and VCU ... mechanism in gene regulation that contributes to the development ... (HCC). Currently, there is virtually no effective treatment for ... for therapeutic intervention. In the journal ...
Cached Medicine News:Health News:Mass. General study reveals how lung cancers evolve in response to targeted treatment 2Health News:Mass. General study reveals how lung cancers evolve in response to targeted treatment 3Health News:Lung Cancer Evolves With Treatment, Study Finds 2Health News:Long-term study: Robot-assisted prostate surgery is safe 2Health News:Trauma Patients Seem More Likely to Survive on Weekends 2Health News:Do all student athletes need heart screenings? 2Health News:Do all student athletes need heart screenings? 3Health News:Discovery in liver cancer cells provides new target for drugs 2
A kit will amplify and hybridize 100 samples. Kit components include: Primers, PCR Buffer, dNTPS, Taq Polymerase, Hybridization Solution, Quick-Light™ Buffer, 20 X SSC Concentrate, Lumi-Phos&re...
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of LH in human serum or plasma. LH in the sample is bound by 2 monoclonal anti-LH antibodies directed at different epito...
... II Direct to High Res SSP kits provide high ... tray. Locus specific typing on a single tray reduces ... Straight from genomic DNA to high resolution results, no ... typing with a single tray , Unique reaction pattern ...
Medicine Products: